IRLAB publishes the Annual Report for 2024

Gothenburg, Sweden, April 25, 2025 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, announced today that the Annual Report for 2024 is published on the company’s website, www.irlab.se.

IRLAB presents at two Redeye events

IRLAB to present clinical and preclinical data at the AD/PD™ 2025: 19th International Conference on Alzheimer’s & Parkinson’s Diseases